Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print April 5, 2006
Protein Science, DOI: 10.1110/ps.052045306
Copyright © 2006 The Protein Society
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.052045306v1
15/5/1142    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, N. Y.
Right arrow Articles by Koland, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, N. Y.
Right arrow Articles by Koland, J. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structure and dynamics of the epidermal growth factor receptor C-terminal phosphorylation domain

Nam Y. Lee1, Theodore L. Hazlett2 and John G. Koland1

1 Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242-1109, USA
2 Laboratory for Fluorescence Dynamics, Department of Physics, University of Illinois, Urbana, Illinois 61801-3080, USA

(RECEIVED December 14, 2005; FINAL REVISION February 7, 2006; ACCEPTED February 7, 2006)

The C-terminal phosphorylation domain of the epidermal growth factor receptor is believed to regulate protein kinase activity as well as mediate the assembly of signal transduction complexes. The structure and dynamics of this proposed autoregulatory domain were examined by labeling the extreme C terminus of the EGFR intracellular domain (ICD) with an extrinsic fluorophore. Fluorescence anisotropy decay analysis of the nonphosphorylated EGFR-ICD yielded two rotational correlation times: a longer time, consistent with the global rotational motion of a 60- to 70-kDa protein with an elongated globular conformation, and a shorter time, presumably contributed by segmental motion near the fluorophore. A C-terminally truncated form of EGFR-ICD yielded a slow component consistent with the rotational motion of the 38-kDa kinase core. These findings suggested a structural arrangement of the EGFR-ICD in which the C-terminal phosphorylation domain interacts with the kinase core to move as an extended structure. A marked reduction in the larger correlation time of EGFR-ICD was observed upon its autophosphorylation. This dynamic component was faster than predicted for the globular motion of the 62-kDa EGFR-ICD, suggesting an increase in the mobility of the C-terminal domain and a likely displacement of this domain from the kinase core. The interaction between the SH2 domain of c-Src and the phosphorylated EGFR C-terminal domain was shown to impede its mobility. Circular dichroism spectroscopy indicated that the EGFR C-terminal domain possessed a significant level of secondary structure in the form of {alpha}-helices and beta-sheets, with a marginal change in beta-sheet content occurring upon phosphorylation.

Keywords: protein tyrosine kinase; ErbB; HER; fluorescence anisotropy


Reprint requests to: John G. Koland, Department of Pharmacology, University of Iowa, Bowen Science Building, Iowa City, IA 52242-1109, USA; e-mail: john-koland{at}uiowa.edu; fax: (319) 335-8930.

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.052045306.

Abbreviations: EGFR, epidermal growth factor receptor; SH2, Src homology-2; PTB, phosphotyrosine binding; PTK, protein tyrosine kinase; A-loop, activation loop; ICD, intracellular domain; CD, circular dichroism; {Delta}CT, C-terminal truncation; CBD, chitin-binding domain; EDANS, 5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid; CEDANS, cysteine- conjugated EDANS; EGFR-CT, C-terminal domain of EGFR; GST, glutathione-S-transferase; TNP-ATP, 2'(3')-O-(2,4,6-trinitrophenyl)-adenosine 5'-triphosphate.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Schade, S. H.L. Lam, D. Cernea, V. Sanguin-Gendreau, R. D. Cardiff, B. L. Jung, M. Hallett, and W. J. Muller
Distinct ErbB-2 Coupled Signaling Pathways Promote Mammary Tumors with Unique Pathologic and Transcriptional Profiles
Cancer Res., August 15, 2007; 67(16): 7579 - 7588.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by The Protein Society.